An insight into cortisol and polymyositis control with steroid therapy

Medical Hypotheses

Volumn 57, Issue 1, 2001, Pages 76-86

  Golding, E M ^a,c   Golding, R M ^b  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b TOWNSVILLE HOSPITAL   (Australia)

^c Department of Anesthesiology ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CORTICOSTEROID; CYCLOSPORIN; DEXAMETHASONE; HYDROCORTISONE; METHOTREXATE; PREDNISOLONE;

ARTICLE; BECKER MUSCULAR DYSTROPHY; CLINICAL OBSERVATION; HUMAN; MATHEMATICAL MODEL; MUSCLE ATROPHY; MUSCLE CONTRACTION; POLYMYOSITIS; PREDICTION; PRIORITY JOURNAL; STEROID THERAPY; TREATMENT OUTCOME;

EID: 0035758247     PISSN: 03069877     EISSN: None     Source Type: Journal    
DOI: 10.1054/mehy.2001.1308     Document Type: Article

References (7)

1. Thorwald J. Science and secrets of early medicine. UK: Thames and Hudson Ltd, 1962.
2. Brophy T., Chalk J. B., Ridgeway K., Tyrer J. H., Eadie M. J. Cortisol production during high dose dexamethasone therapy in neurological and neurosurgical patients. J Neurol Neurosurg Psychiatry 1984; 47: 1081-1086.
3. Villalba L., Adams E. M. Update on therapy for refractory dermatomyositis and polymyositis. Curr Opin Rheumatol 1996; 8: 544-551.
4. Lundberg I., Chung Y. Treatment and investigation of idiopathic inflammatory myopathies. Rheumatology 2000; 39: 7-17.
5. Maegaki Y., Ogura K., Maeoka Y., Takeshita K. Normalization of creatine kinase level during arthritis in a patient with Becker muscular dystrophy. Neurology 1999; 52: 172-174.
6. 31P MRS spectra in determining intracellular free magnesium and potassium ion concentrations. Magn Reson Med 1995; 33: 467-474.
7. Oddis C. V. Therapy of inflammatory myopathy. Rheum Dis Clin North Am 1994; 20: 899-918.